Dissection of the mechanism of traditional Chinese medical prescription-Yiqihuoxue formula as an effective anti-fibrotic treatment for systemic sclerosis
Open Access
- 7 July 2014
- journal article
- research article
- Published by Springer Nature in BMC Complementary and Alternative Medicine
- Vol. 14 (1) , 224
Abstract
Systemic sclerosis (SSc) is a connective tissue fibrotic disease for which there is no effective treatment. Traditional Chinese Medicine (TCM), such as the Yiqihuoxue formula used in Shanghai TCM-integrated Hospital, has shown the efficacy of anti-fibrosis in clinical applications. This study was aiming to dissect the anti-fibrotic mechanism of Yiqihuoxue treatment for SSc. Bleomycin-induced mice and SSc dermal fibroblasts were treated with Yiqihuoxue decoction; NIH-3T3 fibroblasts were exposed to exogenous TGF-β1, and then cultured with or without Yiqihuoxue decoction. Luciferase reporter gene assay was used to determine the activity of Smad binding element (SBE). Quantitative reverse transcription-polymerase chain reaction (RT-PCR) was used to examine the mRNA levels of extracellular matrix (ECM) genes. The protein levels of type I collagen, Smad3 and phosphorylated-Smad3 (p-Smad3) were detected by western blotting. Student’s t-tests were used to determine the significance of the results. Bleomycin-induced mice, SSc dermal fibroblasts and TGF-β1-induced NIH/3T3 fibroblasts showed higher levels of ECM gene transcriptions and collagen production. In addition, the phosphorylation level of Smad3 and activity of SBE were significantly increased after exogenous TGF-β1 induction. Whereas, Yiqihuoxue treatment could obviously attenuate fibrosis in bleomycin-induced mice, down regulate ECM gene expressions and collagen production in SSc dermal fibroblasts and TGF-β1-induced NIH/3T3 fibroblasts. Furthermore, the aberrantly high phosphorylation level of Smad3 and activity of SBE in the TGF-β1-induced NIH/3T3 fibroblasts were also dramatically decreased by Yiqihuoxue treatment. Yiqihuoxue treatment could effectively reduce collagen production via down-regulating the phosphorylation of Smad3 and then the activity of SBE, which are involved in the TGF-β pathway and constitutively activated in the progression of SSc.Keywords
This publication has 42 references indexed in Scilit:
- Role of Endothelial to Mesenchymal Transition in the Pathogenesis of the Vascular Alterations in Systemic SclerosisISRN Rheumatology, 2013
- Cardiovascular Effects of Salvianolic Acid BEvidence-Based Complementary and Alternative Medicine, 2013
- Salvianolic Acid B Attenuates Rat Hepatic Fibrosis via Downregulating Angiotensin II SignalingEvidence-Based Complementary and Alternative Medicine, 2012
- The Function of SPARC as a Mediator of FibrosisThe Open Rheumatology Journal, 2012
- Salvianolic Acid B Inhibits ERK and p38 MAPK Signaling in TGF-1-Stimulated Human Hepatic Stellate Cell Line (LX-2) via Distinct PathwaysEvidence-Based Complementary and Alternative Medicine, 2012
- A standardized extract from Paeonia lactiflora and Astragalus membranaceus attenuates liver fibrosis induced by porcine serum in ratsInternational Journal of Molecular Medicine, 2011
- Salvianolic acids: small compounds with multiple mechanisms for cardiovascular protectionJournal of Biomedical Science, 2011
- Attenuation of fibrosis in vitro and in vivo with SPARC siRNAArthritis Research & Therapy, 2010
- Dissection of mechanisms of Chinese medicinal formula Realgar- Indigo naturalis as an effective treatment for promyelocytic leukemiaProceedings of the National Academy of Sciences, 2008
- Overview of pathogenesis of systemic sclerosisRheumatology, 2006